Citigroup: The US decision to remove Pharmacogon from the 1260H list is a significant benefit for the stock and may boost market sentiment across the Chinese executive segment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.